Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Apraglutide Phase 2 in SBS-IF
NCT03415594Phase 2Completed
- Sponsor
- GLyPharma Therapeutic
- Start
- May 2018
- Primary completion
- Nov 2019
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of apraglutide in short bowel syndrome (SBS), sponsored by GLyPharma Therapeutic. Started May 2018; status: completed.
02
Drugs
apraglutide
03
Conditions
short bowel syndrome (SBS)
Beyond the preview
Go deeper on NCT03415594.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03415594.